AG01
Product Specifications
Target
Src|||TAM Receptor|||c-Met/HGFR|||MMP|||ERK|||HIF/HIF Prolyl-Hydroxylase|||Akt|||VEGFR
Related Pathways
PI3K/Akt/mTOR signaling|||MAPK|||Angiogenesis|||Proteases/Proteasome|||Metabolism|||Chromatin/Epigenetic|||Cytoskeletal Signaling|||Tyrosine Kinase/Adaptors
Bioactivity
AG01 is a monoclonal antibody targeting the anti-granular protein precursor (GP88) . It inhibits the proliferation and migration of triple-negative breast cancer (TNBC) cells, reducing the expression of phosphorylated protein kinases such as p-Src, p-AKT, and p-ERK, as well as oncogenic proteins like Axl, c-MET, HIF-1?, and VEGF. In TNBC xenograft mouse models, AG01 suppresses tumor growth and the expression of Ki67 in vivo. AG01 is useful for research involving cancers like TNBC.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
041370-AP 200 µL
S39A8, ID (SLC39A8, BIGM103, ZIP8, Zinc transporter ZIP8, BCG-induced integral membrane protein in monocyte clone 103 protein, LIV-1 subfamily of ZIP zinc transporter 6, Solute carrier family 39 member 8, Zrt- and Irt-like protein 8) (AP) discontinued
Ask
View Details 
